Trial Information

Summary: Phase III, Efficacy Study and Long Term Safety Assessment of Intermittent Therapy in Patients with Symptoms due to Benign Prostatic Hyperplasia (BPH)

One year placebo controlled efficacy study followed by Open-label extension phase of intermittent dosage regimens of intramuscular injections for the treatment of symptoms due to BPH (Benign Prostatic Hyperplasia)

Patient Inclusion Criteria:

  • Men, 50 years and older
  • BPH, based on medical history
  • Voiding Symptoms due to BPH

Patient Exclusion Criteria:

  • Urgent need for Prostate Surgery
  • Prior Surgical Treatment of Prostate or Bladder
  • High PSA

Contact:

Cheryl Ahlstrom, Recruitment Manager
South Florida Medical Research
21150 Biscayne Blvd. #300
Aventura, FL 33180
Telephone: 305-931-8080 ext. 21
Fax: 305-931-8088
Email:

Profile Page: South Florida Medical Research, Aventura, FL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:37:04 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA